Mun K. Hong / Eyal Herzog (eds.)

Acute Coronary Syndrome

Multidisciplinary and Pathway-Based Approach
Ed. by Mun K. Hong and Eyal Herzog

• Broschiertes Buch

Produktbeschreibung

Edited by two leading cardiologists from St. Luke s-Roosevelt Hospital Center in New York, this book offers practical algorithms for obtaining quick, accurate diagnoses and providing optimal treatment for patients with acute coronary syndrome (ACS). You ll discover the pros and cons and all the considerations that go into choosing the most effective interventional and non-invasive techniques for treating different ACS conditions.

Produktdetails

• Verlag: Springer, Berlin
• Artikelnr. des Verlages: 12037995
• 2008
• Seitenzahl: 344
• Erscheinungstermin: 29. November 2007
• Englisch
• Abmessung: 235mm x 155mm x 22mm
• Gewicht: 584g
• ISBN-13: 9781846288685
• ISBN-10: 1846288681
• Artikelnr.: 22614494

Autorenporträt

Mun K. Hong, St. Luke?s-Roosevelt Hospital Center, New York, NY, USA / Eyal Herzog, St. Luke?s-Roosevelt Hospital Center, New York, NY, USA

Inhaltsangabe

ACS.- The PAIN Pathway for Management of ACS.- Translation of Critical Pathways for ACS into Admission Notes and Discharge Planning.- Epidemiology and Pathophysiology of ACS.- Evaluation in the Emergency Department and Cardiac Biomarkers.- STEMI.- Non STEMI.- Unstable Angina.- Stress Testing for Risk Stratification of Patients at Low to Intermediate Event Risk According to the "PAIN Pathway" Algorithm.- Echocardiography.- Mechanical Complications of AMI.- Congestive Heart Failure.- Cardiogenic Shock.- Pericardial Disease.- Surgical Intervention.- Arrhythmias Complicating AMI-Bradyarrhythmias.- Arrhythmias Complicating AMI.- Ventricular Arrhythmias in Patients Post MI.- Cocaine-Induced Chest Pain.- Women and the Elderly.- African Americans and Hispanics.- Coronary Artery Spasm and Chest Pain with Normal Coronary Arteries.- Antihypertensive Therapy.- Hyperglycemia Complicating ACS: Algorithm for Hyperglycemia Management During ACS.- Transition from Acute Phase to Chronic Phase: Secondary Prevention for Patients with Cardiovascular Disease.- Smoking Cessation.- Future Developments.